These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26220091)

  • 21. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests.
    Castelli FA; Rosati G; Moguet C; Fuentes C; Marrugo-Ramírez J; Lefebvre T; Volland H; Merkoçi A; Simon S; Fenaille F; Junot C
    Anal Bioanal Chem; 2022 Jan; 414(2):759-789. PubMed ID: 34432105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Unified Conceptual Framework for Metabolic Phenotyping in Diagnosis and Prognosis.
    Everett JR; Holmes E; Veselkov KA; Lindon JC; Nicholson JK
    Trends Pharmacol Sci; 2019 Oct; 40(10):763-773. PubMed ID: 31511194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
    Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
    Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolomics has the potential to improve drug therapy].
    Stage C; Jürgens G; Dalhoff KP; Rasmussen HB
    Ugeskr Laeger; 2014 Mar; 176(6):. PubMed ID: 25096206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical metabolomics: a pivotal tool for companion diagnostic development and precision medicine.
    Tolstikov V; Akmaev VR; Sarangarajan R; Narain NR; Kiebish MA
    Expert Rev Mol Diagn; 2017 May; 17(5):411-413. PubMed ID: 28317395
    [No Abstract]   [Full Text] [Related]  

  • 26. Emerging applications of metabolomics in drug discovery and precision medicine.
    Wishart DS
    Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of precision medicine: towards a more predictive personalized medicine.
    Elemento O
    Emerg Top Life Sci; 2020 Sep; 4(2):175-177. PubMed ID: 32856697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolomics side of frailty: Toward personalized medicine for the aged.
    Picca A; Coelho-Junior HJ; Cesari M; Marini F; Miccheli A; Gervasoni J; Bossola M; Landi F; Bernabei R; Marzetti E; Calvani R
    Exp Gerontol; 2019 Oct; 126():110692. PubMed ID: 31421185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine.
    Pintus R; Bassareo PP; Dessì A; Deidda M; Mercuro G; Fanos V
    Biomed Res Int; 2017; 2017():6970631. PubMed ID: 28758121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
    Frédérich M; Pirotte B; Fillet M; de Tullio P
    J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometry based proteomics and metabolomics in personalized oncology.
    Kowalczyk T; Ciborowski M; Kisluk J; Kretowski A; Barbas C
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165690. PubMed ID: 31962175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frontiers of high-throughput metabolomics.
    Zampieri M; Sekar K; Zamboni N; Sauer U
    Curr Opin Chem Biol; 2017 Feb; 36():15-23. PubMed ID: 28064089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
    Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
    Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of personalized and precision medicine: Pharmacometabolomic applications to rare cancer, microbiological investigation, and therapy.
    Cristoni S; Bernardi LR; Malvandi AM; Larini M; Longhi E; Sortino F; Conti M; Pantano N; Puccio G
    Rapid Commun Mass Spectrom; 2021 Jan; 35(2):e8976. PubMed ID: 33053249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized medicine: potential, barriers and contemporary issues.
    Sorich MJ; McKinnon RA
    Curr Drug Metab; 2012 Sep; 13(7):1000-6. PubMed ID: 22591350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies.
    Eckhart AD; Beebe K; Milburn M
    Clin Transl Sci; 2012 Jun; 5(3):285-8. PubMed ID: 22686208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer.
    Darshi M; Van Espen B; Sharma K
    Am J Nephrol; 2016; 44(2):92-103. PubMed ID: 27410520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders.
    Pedrini M; Cao B; Nani JVS; Cerqueira RO; Mansur RB; Tasic L; Hayashi MAF; McIntyre RS; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():182-188. PubMed ID: 30904564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.